Endo Inc.

In News

Soleno Therapeutics Presents New VYKAT® XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period - PR Newswire

PR Newswire - Jun 15, 2026

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS - Business Wire

Business Wire - May 18, 2026

Mineralys Therapeutics to Present Late-Breaking Data on - GlobeNewswire

GlobeNewswire - Jun 08, 2026

With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health - Fierce Pharma

Fierce Pharma - Nov 11, 2025

Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Popular anxiety drug clonazepam recalled for labeling error - ABC News - Breaking News, Latest News and Videos

ABC News - Breaking News, Latest News and Videos - Nov 19, 2025

Par Health Q4 Spin-Off Lined Up As Mallinckrodt, Endo Conclude $6.7bn Merger - insights.citeline.com

insights.citeline.com - Aug 27, 2025

Pryor Cashman Represents Wilmington Savings Fund Society, FSB, in $1.35B Secured Credit Facility for Mallinckrodt–Endo Merger - Pryor Cashman LLP

Pryor Cashman LLP - Aug 04, 2025

Endocyclic’s ENDO-205 awarded NIH grant for endometriosis - BioWorld News

BioWorld News - Sep 17, 2025

Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States - PR Newswire

PR Newswire - Oct 20, 2025

Endo to Combine With Mallinckrodt in $6.7 Billion Deal - Paul, Weiss

Paul, Weiss - Mar 13, 2025

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 - GlobeNewswire

GlobeNewswire - Jun 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment